Abstract
The aim of our study was to compare in a multicentric randomized trial two regimens widely used in the treatment of advanced-stage intermediate- to high-grade non-Hodgkin's lymphoma and to assess whether a third-generation regimen (methotrexate with leucovorin, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin [MACOP-B]) was superior to a second-generation regimen (procarbazine, methotrexate with leucovorin, doxorubicin, cyclophosphamide, and etoposide [ProMACE-MOPP]). Between January 1987 and August 1991, 221 patients with diffuse intermediate- to high-grade non-Hodgkin's lymphoma (Working Formulation groups F, G, H, and K), stage II bulky (> 10 cm), III, or IV, were randomized by the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG) to receive ProMACE-MOPP for six cycles or MACOP-B for 12 weeks. Survival, progression-free survival, and disease-free survival were determined, and multivariate analysis of prognostic factors was performed. In the two groups of patients, there was no significant difference in terms of complete remission (CR) rate (49.1% with ProMACE-MOPP and 52.3% with MACOP-B), 3-year overall survival rate (45.2% with PROMACE-MOPP and 52.3% with MACOP-B), and 3-year progression-free surv...Continue Reading
Citations
Nov 1, 1996·European Journal of Haematology·E MontserratJ Estapé
Apr 30, 1999·Leukemia & Lymphoma·G SantiniE Damasio
Dec 18, 2001·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R C BaldisseraC A De Souza
Oct 29, 2002·Leukemia & Lymphoma·Michael CrumpElizabeth Eisenhauer
Aug 14, 2013·Pediatric Blood & Cancer·Daniel M GreenLeslie L Robison
Apr 27, 2004·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·G SantiniUNKNOWN Italian Non-Hodgkin's Lymphoma Co-operative Study Group
Jan 22, 2004·Hematological Oncology·Timothy J LittlewoodUNKNOWN Epoetin Alfa Study Group
Jul 2, 2011·Leukemia·G S NowakowskiT E Witzig
Aug 20, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grzegorz S NowakowskiThomas E Witzig
Oct 8, 1999·Journal of the National Cancer Institute·J E Groopman, L M Itri
Dec 1, 1996·Medical Oncology·H Hagberg, E Kimby
Apr 24, 2010·Annals of Hematology·Tsuneaki HirakawaKazuo Dan
Nov 14, 2006·Cancer·Ivana N M MicallefThomas M Habermann
Oct 6, 2015·Annals of Hematology·Yoshikazu UtsuHisashi Wakita
Feb 25, 1998·Cancer Investigation·E R Gaynor, R I Fisher
Mar 25, 2008·Therapeutics and Clinical Risk Management·Jean-Pierre ArmandLauren Abrey
Jan 27, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L LeeM Crump